Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™
R&D Inquiry Quote
Contact Us Telecon Calls

Apta-Index™: VEGF-KDR (ID# 233)

Back to Search Results

VEGF-KDR (ID# 233)

* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
Peptide VEGF-KDR Tissue ~80 µM (reported value) Binding Buffer: DMEM supplemented with 20 mM HEPES (pH 7.4) and 2 mg/mL gelatin N/A If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding. Reduces VEGF-induced angiogenesis and blocks VEGF-KDR interaction.
7 886.11 g/mole

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

Binetruy-Tournaire et al. "Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis." The EMBO Journal, 19(2000): 1525-1533.

Have your aptamer oligo synthesized by one of our AFFILIATES

Community Feedback

Aptagen, LLC | 250 North Main Street | Jacobus, PA 17407

Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™
Contact Us Telecon Calls